ProPhase Labs, Inc. (PRPH)

Market Cap	979.00K
Revenue (ttm)	5.06M
Net Income (ttm)	-41.70M
Shares Out	4.62M
EPS (ttm)	-11.64
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	543,281
Average Volume	2,957,716
Open	0.2410
Previous Close	0.2450
Day's Range	0.1867 - 0.2599
52-Week Range	0.1661 - 7.8000
Beta	-0.54
RSI	16.51
Earnings Date	Mar 27, 2026

About ProPhase Labs

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart Esophageal Pre-Cancer diagnostics screening test for early detection of esophageal cancer; genomics testing technologies to analyze entire genomes, inc...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1989
• Employees: 96
• Stock Exchange: OTCMKTS
• Ticker Symbol: PRPH

Financial Performance

In 2024, ProPhase Labs's revenue was $6.77 million, a decrease of -80.65% compared to the previous year's $34.98 million. Losses were -$53.36 million, 218.0% more than in 2023.